… Results are in from a study of glial cell line-derived neurotrophic factor … could be due to placebo effect. Details on the study from Clare Wilson in  NewScientist : In the first stage of … J. Fox Foundation (MJFF)  supported earlier studies of GDNF from MedGenesis , the biotechnology company that developed …

… movement takes place in human nerve cells derived from stem cells donated by people with PD and whether this … they move within the processes of nerve cells in vitro . From a repository of human induced pluripotent stem cells, …

… that deep learning can extract important signals from gait records collected from wearable devices, which can be further correlated with … to each other. mPower data are much diversely sampled -- from more than 3,000 unique participants -- so we expect the …

… that people with Parkinson's disease (PD) benefited from the treatment with GLP1 agonist exenatide. How activation of the GLP1 receptor may protect cells from neurodegeneration will predict whether the GLP1 … inherited Parkinson's and identify people who may benefit from GLP1 agonists. Impact on Diagnosis/Treatment of …

… grant was to develop a patient-derived stem cell model from skin cells with different expression levels of protein … in the alpha-synuclein gene. Differentiated neuronal cells from these cell lines showed differences in the composition … differentiated neuronal cultures in all cell lines ranging from no alpha-synuclein expression (0 functional …

… elements, which are viral-like gene fragments left over from viral infections. While transposable elements are … whether transposable elements are active in tissues from patients with Parkinson’s disease and whether this … activity using single-cell RNA sequencing of tissues from people with Parkinson’s disease. This particular …